Inhibikase Therapeutics Inc (IKT)
Operating Cash Flow Growth
-114.08%
TTM · Period ending:
IKT Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-114.08%period ending
Latest reported-114.08%period ending
IKT TTM Cash from Operations YoY % (-48.23% → -114.08%)
Year-over-year change
High-resolution chart · PNG
IKT operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -114.0831% | |
| -84.3871% | |
| -45.1137% | |
| -48.5427% | |
| -20.8606% | |
| -21.3058% | |
| -5.8779% | |
| 5.2424% | |
| 15.969% | |
| 17.5826% | |
| -4.2299% | |
| -1.724% | |
| -36.0419% | |
| -35.6158% | |
| -21.3614% | |
| -60.4855% | |
| -59.155% | |
| -196.8712% | |
| -1,157.3103% | |
| -5,951.561% | |
| -3,296.1591% | |
| -1,478.9843% | |
| -236.1359% | |
| 34.3763% | |
| -48.2265% |